GSK discloses $28,375 in payments to HCPs
Read more - GSK discloses $28,375 in payments to HCPs Read more
These press releases are intended for business journalists and analysts/investors
Read more - GSK discloses $28,375 in payments to HCPs Read more
Read more - GSK increases supply of Menningococcal B vaccine Read more
Read more - New research shows Australians aren’t taking ageing lying down Read more
Read more - Luke Miels appointed President, Global Pharmaceuticals, GSK Read more
First therapy approved for severe refractory eosinophilic asthma to be listed on the PBS
What would happen to Christmas if Santa suffered prostate issues?
#SeatsUpForSanta social initiative puts spotlight on enlarged prostate symptoms
Read more - Santa’s prostate nightmare urges Australian men to act Read more
Read more - GSK invests to support female technology entrepreneurs Read more
GSK tops the Access to Medicines Index for the fifth consecutive time.
Read more - GSK leads Access to Medicine Index 2016 Read more
GSK Consumer Healthcare announced that it will close its manufacturing facility at Ermington, in Sydney’s north-west, in 2020. The decision was made after a thorough evaluation of the site, which revealed the manufacturing site would not be able to remain competitive in the long-term.
All entitlements are protected for the 223 employees whose jobs are affected, and the company will work through the next four years to provide support.
Read more - GSK Consumer Healthcare to close Ermington manufacturing site in 2020 Read more
Read more - Bexsero® (Meningococcal B) vaccine availability Read more